Suppr超能文献

介导 APC 失活引起的肠道肿瘤发生增强

mediates enhancement of intestinal tumorigenesis caused by inactivation of .

机构信息

Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University München, Germany.

German Cancer Consortium (DKTK), D-69120 Heidelberg, Germany.

出版信息

Int J Biol Sci. 2022 Aug 29;18(14):5415-5437. doi: 10.7150/ijbs.75503. eCollection 2022.

Abstract

The CSF1 receptor (CSF1R) encoding mRNA represents a direct target of miR-34a. However, the relevance of the suppression of by miR-34a for intestinal tumor suppression mediated by the p53/miR-34a pathway has remained unknown. Here, mice with intestinal-epithelial cell (IEC)-specific deletions of showed increased formation of adenomas and decreased survival, whereas deletion of decreased adenoma formation and increased survival. In adenomas deletion of enhanced proliferation, STAT3 signaling, infiltration with fibroblasts, immune cells and microbes, and tumor stem cell abundance and decreased apoptosis. Deletion of had the opposite effects. In addition, homeostasis of intestinal secretory and stem cells, and tumoroid formation were affected in opposite directions by deletion of and . Concomitant deletion of and neutralized the effects of the single deletions. mRNAs containing Mir34a seed-matching sites, which encode proteins related to EMT (epithelial-mesenchymal transition), stemness and Wnt signaling, were enriched after inactivation in adenomas and derived tumoroids. and were characterized as direct targets of Mir34a and Csf1r signaling. -inactivation related expression signatures were associated with CMS4/CRISB+D, stage 4 CRCs and poor patient survival. In tumoroids the loss of conferred resistance to 5-FU which was mediated by . This study provides genetic evidence for a requirement of Mir34a-mediated suppression for intestinal stem/secretory cell homeostasis and tumor suppression, and suggests that therapeutic targeting of CSF1R may be effective for the treatment of CRCs with defects in the p53/miR-34a pathway.

摘要

CSF1 受体(CSF1R)编码 mRNA 是 miR-34a 的直接靶标。然而,miR-34a 对 p53/miR-34a 通路介导的肠道肿瘤抑制的抑制作用的相关性仍然未知。在这里,具有肠上皮细胞(IEC)特异性缺失的小鼠表现出腺瘤形成增加和存活率降低,而缺失则减少了腺瘤的形成并增加了存活率。在腺瘤中,缺失增强了增殖、STAT3 信号传导、成纤维细胞、免疫细胞和微生物的浸润以及肿瘤干细胞的丰度,并降低了细胞凋亡。缺失则产生相反的效果。此外,缺失和的缺失以相反的方式影响肠道分泌细胞和干细胞的平衡以及肿瘤球体的形成。缺失和的同时缺失中和了单个缺失的影响。含有 Mir34a 种子匹配位点的 mRNA,其编码与 EMT(上皮-间质转化)、干细胞特性和 Wnt 信号相关的蛋白质,在腺瘤和衍生的肿瘤球体中失活后被富集。和被表征为 Mir34a 和 Csf1r 信号的直接靶标。与失活相关的表达特征与 CMS4/CRISB+D、CRC 第 4 期和患者预后不良相关。在肿瘤球体中,缺失赋予了对 5-FU 的耐药性,这是由介导的。本研究为 miR-34a 介导的缺失对于肠道干细胞/分泌细胞平衡和肿瘤抑制的需求提供了遗传证据,并表明靶向 CSF1R 的治疗可能对 p53/miR-34a 通路缺陷的 CRC 有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedc/9461672/83954c3a4d99/ijbsv18p5415g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验